Jinyu Bio-technology Co., Ltd. (SHA:600201)

Jinyu Bio-technology Revenue

Jinyu Bio-technology had revenue of 409.98M CNY in the quarter ending June 30, 2026, with 52.98% growth. This brings the company's total for the last twelve months to 1.53B, up 21.37% year-over-year. In the year 2025, Jinyu Bio-technology had annual revenue of 1.40B with 11.23% growth. That makes Jinyu Bio-technology the 16,436th largest company in the world by revenue and 2,958th in China.

• Revenue (ttm): 1.53B
• Revenue Growth: +21.37%
• P/S Ratio: 8.99
• Revenue / Employee: 815.14K
• Employees: 1,881
• Market Cap: 13.65B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biopharmaceutical 1.29B 96.4%
• Other income 48.60M 3.6%

By Geography

Chart

• China 1.32B 98.5%
• Abroad 20.55M 1.5%

Fiscal year ended Dec 31, 2025 See the full Jinyu Bio-technology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.40B	140.96M	11.23%
Dec 31, 2024	1.26B	-342.77M	-21.45%
Dec 31, 2023	1.60B	69.56M	4.55%
Dec 31, 2022	1.53B	-247.65M	-13.94%
Dec 31, 2021	1.78B	194.41M	12.29%

Data Source: S&P Global Market Intelligence Last updated: Aug 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error